I. Vanlinthout

427 total citations
17 papers, 363 citations indexed

About

I. Vanlinthout is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, I. Vanlinthout has authored 17 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in I. Vanlinthout's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Blood properties and coagulation (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). I. Vanlinthout is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Blood properties and coagulation (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). I. Vanlinthout collaborates with scholars based in Belgium, Japan and Germany. I. Vanlinthout's co-authors include D Collen, Jean Marie Stassen, H.R. Lijnen, Désiré Collen, H.R. Lijnen, N. Nagai, Marc Jacquemin, Marie‐Christine Rio, Jaan Toelen and B. Van Hoef and has published in prestigious journals such as Circulation, Blood and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

I. Vanlinthout

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Vanlinthout Belgium 10 154 153 97 90 76 17 363
Senichiro Hashimoto Japan 10 101 0.7× 305 2.0× 68 0.7× 55 0.6× 45 0.6× 15 422
Ashley Ringrose Canada 5 33 0.2× 182 1.2× 90 0.9× 19 0.2× 30 0.4× 6 326
J.H. Verheijen Netherlands 9 154 1.0× 87 0.6× 106 1.1× 21 0.2× 37 0.5× 16 371
Tobias Silzle Switzerland 10 78 0.5× 97 0.6× 164 1.7× 27 0.3× 25 0.3× 20 427
Melanie E. DeFord United States 7 173 1.1× 81 0.5× 197 2.0× 68 0.8× 12 0.2× 9 366
Chunmei Wu China 9 35 0.2× 67 0.4× 87 0.9× 24 0.3× 16 0.2× 15 338
Stephan Macher-Göppinger Germany 8 37 0.2× 40 0.3× 146 1.5× 56 0.6× 18 0.2× 16 311
Shashank Jain United States 3 21 0.1× 137 0.9× 61 0.6× 37 0.4× 20 0.3× 7 249
Kathrin Paul Germany 7 110 0.7× 20 0.1× 207 2.1× 27 0.3× 52 0.7× 9 355
Áine M. Prendergast Germany 8 52 0.3× 295 1.9× 218 2.2× 51 0.6× 11 0.1× 14 543

Countries citing papers authored by I. Vanlinthout

Since Specialization
Citations

This map shows the geographic impact of I. Vanlinthout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Vanlinthout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Vanlinthout more than expected).

Fields of papers citing papers by I. Vanlinthout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Vanlinthout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Vanlinthout. The network helps show where I. Vanlinthout may publish in the future.

Co-authorship network of co-authors of I. Vanlinthout

This figure shows the co-authorship network connecting the top 25 collaborators of I. Vanlinthout. A scholar is included among the top collaborators of I. Vanlinthout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Vanlinthout. I. Vanlinthout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jacquemin, Marc, et al.. (2020). Optimization of the detection of inhibitory autoantibodies against the VWF‐cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay. International Journal of Laboratory Hematology. 43(2). 290–297. 2 indexed citations
2.
3.
Jacquemin, Marc, Jaan Toelen, Luc Feyen, et al.. (2018). The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays. International Journal of Laboratory Hematology. 40(4). 442–447. 30 indexed citations
4.
5.
Jacquemin, Marc, I. Vanlinthout, Jaan Toelen, et al.. (2017). The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG‐Arg301 to be distinguished from hypofibrinogenemia. International Journal of Laboratory Hematology. 39(3). 301–307. 10 indexed citations
6.
Jacquemin, Marc, Jaan Toelen, I. Vanlinthout, et al.. (2015). The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders. Journal of Thrombosis and Haemostasis. 13(11). 2087–2092. 35 indexed citations
7.
Moons, Lieve, I. Vanlinthout, I. Roelants, et al.. (2001). Toxicology Studies with Recombinant Staphylokinase and with SY 161-P5, a Polyethylene Glycol-Derivatized Cysteine-Substitution Mutant. Toxicologic Pathology. 29(3). 285–291. 6 indexed citations
8.
Vanwetswinkel, Sophie, Stéphane Plaisance, Zhiyong Zhang, et al.. (2000). Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase. Blood. 95(3). 936–942. 33 indexed citations
9.
Lijnen, H.R., et al.. (1999). Accelerated Neointima Formation After Vascular Injury in Mice With Stromelysin-3 (MMP-11) Gene Inactivation. Arteriosclerosis Thrombosis and Vascular Biology. 19(12). 2863–2870. 47 indexed citations
10.
11.
Lijnen, Roger, et al.. (1997). Plasminogen activator (PA) and matrix metalloproteinase (MMP) system function after vascular injury in mice with targeted inactivation of fibrinolytic genes. Thrombosis and Haemostasis. 1 indexed citations
12.
Stassen, Jean–Marie, Hans J. Rapold, I. Vanlinthout, & D Collen. (1993). Comparative Effects of Enoxaparin and Heparin on Arterial and Venous Clot Lysis with Alteplase in Dogs. Thrombosis and Haemostasis. 69(5). 454–459. 8 indexed citations
13.
Collen, D, F De Cock, I. Vanlinthout, et al.. (1992). Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinase. Fibrinolysis and Proteolysis. 6(4). 232–242. 44 indexed citations
14.
Stassen, Jean Marie, H.R. Lijnen, I. Vanlinthout, & D Collen. (1991). Thrombolysis with bolus injections and infusions of tissue-type plasminogen activator in rabbits with experimental jugular vein thrombosis. Fibrinolysis and Proteolysis. 5(3). 165–170. 6 indexed citations
15.
16.
Lijnen, H.R., Jean Marie Stassen, I. Vanlinthout, et al.. (1991). Comparative Fibrinolytic Properties of Staphylokinase and Streptokinase in Animal Models of Venous Thrombosis. Thrombosis and Haemostasis. 66(4). 468–473. 44 indexed citations
17.
Stassen, Jean Marie, I. Vanlinthout, H.R. Lijnen, & D Collen. (1990). A hamster pulmonary embolism model for the evaluation of the thrombolytic and pharmacokinetic properties of thrombolytic agents. Fibrinolysis and Proteolysis. 4. 15–21. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Senichiro Hashimoto Breakdown of academic impact, for papers by Ashley Ringrose Breakdown of academic impact, for papers by J.H. Verheijen Breakdown of academic impact, for papers by Tobias Silzle Breakdown of academic impact, for papers by Melanie E. DeFord Breakdown of academic impact, for papers by Chunmei Wu Breakdown of academic impact, for papers by Stephan Macher-Göppinger Breakdown of academic impact, for papers by Shashank Jain Breakdown of academic impact, for papers by Kathrin Paul Breakdown of academic impact, for papers by Áine M. Prendergast
Rankless by CCL
2026